share_log

Glucotrack Completes 60-Day Preclinical Study Of Implantable Continuous Glucose Monitor; Confirms Potential For Simplified Management Of Painful Diabetic Neuropathy

Glucotrack Completes 60-Day Preclinical Study Of Implantable Continuous Glucose Monitor; Confirms Potential For Simplified Management Of Painful Diabetic Neuropathy

Glucotrack完成了植入式持续血糖监测仪60天的临床研究,确认其在疼痛性糖尿病性神经病变简化管理方面的潜力。
Benzinga ·  06/13 09:20

Glucotrack Completes 60-Day Preclinical Study Of Implantable Continuous Glucose Monitor; Confirms Potential For Simplified Management Of Painful Diabetic Neuropathy

Glucotrack完成了植入式持续血糖监测仪60天的临床研究,确认其在疼痛性糖尿病性神经病变简化管理方面的潜力。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发